博济医药 (300404.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

72.7x

Market Cap

CNY 5.46B

MomentumView details →

1D Return

−1.94%

YTD Return

+33.23%

RSI (14)

47.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

72.7x

Market Cap

CNY 5.46B

RSI (14)

47.3

MomentumView details →

1D Return

−1.94%

YTD Return

+33.23%

ProfitabilityView details →

Gross Margin

26.92%

Net Margin

4.53%

EBITDA Margin

6.81%

ROE (TTM)

4.03%

ROA (TTM)

2.58%

Asset Turnover

0.58x

GrowthView details →

Revenue YoY

+33.15%

EPS YoY

+165.49%

FCF YoY

+55.05%

Revenue CAGR 3Y

+27.04%

EPS CAGR 3Y

+1.78%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.04x

Current Ratio

1.92x

Quick Ratio

1.47x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

949.94M

Net Income (TTM)

43.05M

Op. CF (TTM)

67.05M

Latest newsMore news →

Boji Pharmaceutical signed a cooperation agreement with Huawei Technologies on September 1, 2026, to jointly explore innovative applications in the 'AI+CRO' field by integrating biopharmaceutical CRO expertise with AI and cloud computing technologies.2d ago

Boji Medical and the Affiliated Hospital of Changchun University of Chinese Medicine signed a strategic cooperation agreement on August 11, 2026, to collaborate on drug and medical device clinical trials, clinical research talent training, and commercialization of traditional Chinese medicine research results.25d ago

Similar companies

中机认检301508.SZ 广东建科301632.SZ 钢研纳克300797.SZ 诺思格301333.SZ 百诚医药301096.SZ 联检科技301115.SZ

Latest newsMore news →

Boji Pharmaceutical signed a cooperation agreement with Huawei Technologies on September 1, 2026, to jointly explore innovative applications in the 'AI+CRO' field by integrating biopharmaceutical CRO expertise with AI and cloud computing technologies.2d ago Boji Medical and the Affiliated Hospital of Changchun University of Chinese Medicine signed a strategic cooperation agreement on August 11, 2026, to collaborate on drug and medical device clinical trials, clinical research talent training, and commercialization of traditional Chinese medicine research results.25d ago